Your browser doesn't support javascript.
loading
Significant therapeutic effectiveness of durvalumab after chemoradiotherapy for a patient with post-operative recurrent pulmonary pleomorphic carcinoma.
Shimamura, So; Saiki, Masafumi; Ide, Shuichiro; Masuda, Kazuki; Uchida, Yoshinori; Sogami, Yusuke; Kasai, Kazunari; Inoue, Tomohiro; Ishihara, Hiroshi.
Afiliación
  • Shimamura S; Department of Internal Medicine II, Faculty of Medicine University of Yamanashi Chuo Japan.
  • Saiki M; Department of Internal Medicine II, Faculty of Medicine University of Yamanashi Chuo Japan.
  • Ide S; Department of Internal Medicine II, Faculty of Medicine University of Yamanashi Chuo Japan.
  • Masuda K; Department of Internal Medicine II, Faculty of Medicine University of Yamanashi Chuo Japan.
  • Uchida Y; Department of Internal Medicine II, Faculty of Medicine University of Yamanashi Chuo Japan.
  • Sogami Y; Department of Internal Medicine II, Faculty of Medicine University of Yamanashi Chuo Japan.
  • Kasai K; Department of Pathology, Faculty of Medicine University of Yamanashi Chuo Japan.
  • Inoue T; Department of Pathology, Faculty of Medicine University of Yamanashi Chuo Japan.
  • Ishihara H; Department of Internal Medicine II, Faculty of Medicine University of Yamanashi Chuo Japan.
Respirol Case Rep ; 9(6): e00781, 2021 Jun.
Article en En | MEDLINE | ID: mdl-34012549
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Respirol Case Rep Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Respirol Case Rep Año: 2021 Tipo del documento: Article